Trials / Completed
CompletedNCT01213160
Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient
A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD4547 in Japanese Patients With Advanced Solid Malignancies
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 25 Years – 150 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to explore the safety and tolerability of AZD4547 in Japanese patients with advanced solid malignancies.
Detailed description
A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD4547 in Japanese Patients with Advanced Solid Malignancies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD4547 | film coated tablet, PO, twice daily |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2010-10-01
- Last updated
- 2016-06-29
Locations
3 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01213160. Inclusion in this directory is not an endorsement.